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a b s t r a c t
Catheter-directed thrombolysis (CDT) is one of the methods in the treatment of patients
with acute lower limb ischemia. It is based on intrathrombus infusion of one of the
thrombolytic agents. The most common complication of CDT is bleeding.
We present a patient with left lower limb ischemia, treated by CDT, in which symptoms
of stroke, proved to have ischemic etiology, started during continuous intra-arterial infusion
of rt-PA. As the patient presented with the history of atrial ﬁbrillation, the most probable
mechanism of stroke was related to detachment of possible intra-atrial thrombus. Ischemic
stroke which happened during intra-arterial thrombolysis with rt-PA has never been
mentioned in literature yet and the case stands for the statement that very effective
causative treatment of ischemic stroke with rt-PA is not sufﬁcient to ‘‘prevent’’ ischemic
stroke if used in very small doses.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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Catheter-directed thrombolysis (CDT) is an alternative method
to surgical thrombolectomy, anticoagulant therapy and
amputation in the treatment of patients with acute lower
limb ischemia. It is used both in acute embolic ischemia and
arterial or graft thrombosis [1]. It is based on intrathrombus
infusion of one of the thrombolytic agents – the major three
that are in use today are urokinase (UK), alteplase (rt-PA –
recombinant tissue plasminogen activator) and reteplase
(mutein of t-PA) [2].* Corresponding author at: Department of Neurology, Stroke and Neuro
90-153 Lodz, Poland. Tel.: +48 42 6776678; fax: +48 42 6786833.
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0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish NCDT is recommended if a patient suffers from acute or sub-
acute ischemia and does not manifest severe loss of sensory
and motor function [1,3]. Patients with immediate limb threat
often require emergent operation, however in some patients
with cardiovascular risks of general anesthesia, thrombolysis
may be the best option [4].
2. Case report
An 82-year-old, right-handed, Caucasian woman was admit-
ted to the Department of General Surgery because of ischemiarehabilitation, Medical University of Lodz, 22 Kopcinskiego Street,
eurological Society.
Fig. 2 – CT scan of the brain at the day of stroke of the
patient.
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treated in the Department of Internal Medicine of another
hospital because of dyspnea and swelling of the lower limbs.
She presented there with a history of chronic coronary heart
disease, myocardial infarction, ﬁxed left bundle branch block,
chronic heart failure, hypertensive disease, chronic obstruc-
tive pulmonary disease, hypercholesterolemia and diabetes
mellitus. Physically, on admission to the Department of
Internal Medicine the patient was in a severe general condition
with clinical symptoms of circulatory and respiratory insufﬁ-
ciency in the course of infection and exacerbation of chronic
obstructive pulmonary disease. ECG revealed atrial tachycar-
dia with atrio-ventricular block 2:1, cardiac rhythm of 135/min.
Over 15 days the patient improved but in the morning on the
following day, the patient complained about pain of the left
lower limb at rest. The left leg was cool and the patient
reported numbness on the dorsal part of the foot while
examined. There was also no pulse found below the left knee.
Duplex Doppler of the lower limb vessels revealed patent left
popliteal artery with moderately impaired ﬂow, which was
monophasic, highly resistant, with slightly lower velocity than
on the right side. Proximal segments of the left shin arteries
were also patent, but distally – about 5 cm below the knee the
Doppler ultrasound signal was absent, which indicated occlu-
sion of those arteries. Angio-CT of the lungs was performed to
exclude pulmonary embolism. ECG showed atrial ﬁbrillation
(AFib). The dose of enoxaparin was increased to 120 mg/day
(60 mg bid). Afterwards the patient was translocated to the
Department of Surgery of our hospital and soon after admission
the procedure of percutaneous catheter directed intra-arterial
thrombolysis (CDT) was initiated. Using the cross-over method
catheter ending was introduced into the thrombus in the tibial
truncus and the left tibial artery. At 00:30 thrombolytic
treatment was started – the patient received a single bolus of
5 ml of Actilyse (rt-PA), and then intravenous infusion of 15 ml
of Actilyse along with 800 mg of heparin infusion were set up.
About 7:00 am the next day a nurse recorded the patient was
unresponsive, without logical verbal contact. Overall until that
time the patient received in total about 12 ml of Actilyse. A
consulting neurologist evaluated the patient as conscious but
without any verbal contact, with ‘‘ﬂoating’’ eyeballs, gazing to
the left. Also features of a lesion of the pathways of the rightFig. 1 – Angiography of the left lower limb with
thrombembolization.facial nerve, paresis of the right limbs and Babinski sign on the
right were found (Figs. 1 and 2).
Computed tomography revealed numerous, diffuse areas of
reduced density that might correspond to post-ischemic
lesions – new ischemic areas might have been masked by
them. Moreover, the lenticular nucleus on the left was slightly
faded and its density was reduced. There were no signs of
intracranial hemorrhage.
Over the day the general state of the patient was slightly
better – she was conscious, trying to comply with the
commands. Complete motor aphasia and paralysis of left
limbs were still present. The patient was transferred to the
Department of Neurology. Initially the patient was in medium-
heavy general state, neurologically stable, with efﬁcient
respiration and circulation. AFib was still being observed –
the patient was given beta-blocker (metoprolol) via intrave-
nous drip. Moreover, acetylsalicylic acid (75 mg po), enox-
aparin (40 mg bid sc), mannitol (100 ml qid iv), furosemide iv,
and ipratropium bromide with salbutamol via nebulization
were administered.
On the next day of hospitalization at 7:40 cardiac arrest
happened. There were neither spontaneous respirations nor
palpable carotid pulses. Cardiopulmonary resuscitation was
begun immediately with 100% oxygen by bag-valve-mask and
closed chest cardiac compressions. The patient was intubated.
Atropine and adrenaline were administered. Tracheal intuba-
tion and mechanical ventilation were substituted for bag-
valve-mask ventilation. Resuscitation was successful, but
there were 2 more cardiac arrests. Dopamine and dobutamine
were administered via intravenous drip. The patient was
unconscious and unresponsive to pain. Periodically, bradycar-
dia about 30/min and systemic blood pressure about 60/
40 mmHg were observed. Despite treatment, bradycardia
worsened, periodically there was no carotid and femoral
pulse. At 10:20 the patient was declared dead.
3. Discussion
Complications of CDT are recorded in about 30% of patients.
Bleeding is the most common (11.3%) complication (access site
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hematomas, gastro-intestinal and renal bleeding, hematuria).
Intracranial hemorrhage is the most dangerous complication
of thrombolytic treatment. Other complications are distal or
proximal embolization, peri-catheter thrombosis, compart-
ment syndrome, lymphocele, and pseudoaneurysm.
Ischemic stroke during intra-arterial infusion of rt-PA has never
been mentioned in literature yet. There is, however, 1
publication addressing 3 cases of ischemia of the brain after
thrombolysis of an occluded limb artery, but in all 3 cases the
thrombolytic agent used was streptokinase [5].
Here we describe a patient in whom two complications of
atrial ﬁbrillation took place almost simultaneously – embolic
arterial occlusion of the left lower limb and ischemic stroke as
an expression of arterial thromboembolism. The patient's
medical history showed several risk factors of ischemic stroke:
arterial hypertension, diabetes mellitus, hypercholesterol-
emia, obesity related to sedentary lifestyle, as well as chronic
coronary heart disease. Symptoms of stroke, which happened to
be of ischemic etiology, started during continuous intravenous
infusion of rt-PA. This effective for revascularization treatment is
used speciﬁcally in acute phase of ischemic stroke, indepen-
dently of etiology, and therefore it is surprising that ischemic
stroke occurred during the therapy of choice of ischemic stroke. It has
to be admitted, however, that the dose of rt-PA used in the
described case was signiﬁcantly smaller than the dose used to
treat stroke. On the other hand, ‘‘treating ischemic stroke’’ is a
different situation from ‘‘no stroke with potential of ischemic
stroke’’. This means that a small dose of potent thrombolytic
agent cannot prevent ischemic stroke which is probably due to
cardiac embolus. It has to be speculated that probably rt-PA
applied for treatment of ischemed limb in a patient with AFib
provoked stroke in the mechanism of possible detaching a
thrombus or thrombi from the left atrium, which then became
an embolus or emboli in the brain arteries. It seems that in
such situation as occlusion of a peripheral artery of a limb in a
patient with AFib embolectomy is a safer procedure than
thrombolysis. This can lower the risk of stroke ‘‘despite’’ or
‘‘because’’ of systemic thrombolytic treatment.Conﬂict of interest
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